Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Nitrendipine in Elderly ISH
NCT00751829Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of olmesartan in isolated systolic hypertension (ISH) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change in mean sitting systolic blood pressure at 12 weeks. Started Jul 2003; status: completed.
02
Drugs
olmesartan
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT00751829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751829.